Royalty Pharma (NASDAQ:RPRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Royalty Pharma missed estimated earnings by 17.81%, reporting an EPS of $0.6 versus an estimate of $0.73.
Revenue was down $11.03 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 0.4% increase in the share price the next day.
Here's a look at Royalty Pharma's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.77 | 0.69 | 0.69 | 0.65 |
| EPS Actual | 0.80 | 0.24 | 0.73 | 0.18 |
| Revenue Estimate | 556.79M | 578.20M | 483.42M | 509.70M |
| Revenue Actual | 576.00M | 585.77M | 555.00M | 573.03M |
To track all earnings releases for Royalty Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
